To develop targeted therapies for CNS disorders characterized by inflammation and seizures, it is essential to understand how kynurenine metabolites both promote and prevent excitotoxicity
Some report that a smaller dose allows them to: Maintain a healthy appetite while reducing food noise Support long-term metabolic health Avoid some of the gastrointestinal side effects that can occur with higher doses Take a more gradual, sustainable approach Again, there is limited research specifically evaluating long-term "microdosing" strategies, so decisions should always be individualized and made with a qualified healthcare professional
There may be edema and the swelling might manifest in the ankles and the arms
Other physical reactions Headaches Dizziness for a few hours Feeling jittery or nervous briefly Mild fever These effects usually disappear within 12 days
Lu J, Zou S, Liu X, Wong TYP, Zhang X, Xu KS, Zhao Y, Hong Y, Cen A, Wang Y
Read together with the failed fosgonimeton trial, the takeaway is that the human-relevant evidence base for this class is both thin and, where it touched humans, negative
